What happens when unexpected manufacturing schedule changes put a patient’s life at risk? In this webinar we examine how Cell and Gene Therapy (C>) products fundamentally change the manufacturing paradigm. “Make-to-stock” with big inventories, have given way to just-in-time scheduling of a batch and all the parallel and converging processes on which it depends, for each and every patient receiving care. This approach leaves no margin for error, because the cascading effects of even small delays can often directly impact patient outcomes and business success.
In this environment, schedulers have a critical role: to jointly coordinate the manufacturing process around the precisely timed needs of individual patients receiving therapy. This involves not just orchestration of patient samples, but a holistic approach that integrates manufacturing, supply chain, Quality Control, equipment maintenance, and operator scheduling seamlessly together. Join us to see how scheduling plays its part in solving the critical issues facing patient-centric, cost-effective C> manufacturing today.